12-Week Trial Investigating L-carnitine Tartrate, Dihydrocapsiate and Protein Yeast Hydrolysate on Energy Intake and Expenditure in Overweight Adults

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

June 26, 2025

Study Completion Date

June 26, 2025

Conditions
Overweight and Obesity
Interventions
COMBINATION_PRODUCT

SPICE BLEND CAPSULE

The study product is a powder mix of L-carnitine tartrate yeast protein hydrolysate and dihydrocapsiate.in the format of hard vegetable green capsules. Participants will consume a total of 4 capsules a day split in two servings.

OTHER

Placebo

The matching placebo is microcrystalline cellulose in the format of hard vegetable green capsules. Participants will consume a total of 4 capsules a day split in two servings.

Trial Locations (1)

W12 0HS

Imperial College Healthcare NHS Trust, Hammersmith Hospital, 72 Du Cane Rd, London

Sponsors
All Listed Sponsors
collaborator

Imperial College London

OTHER

collaborator

Imperial Clinical Trials Unit (ICTU)

UNKNOWN

lead

Société des Produits Nestlé (SPN)

INDUSTRY